ImmunityBio, Inc. IBRX Warrants and Rights Outstanding
Warrants and Rights Outstanding at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s warrants and rights outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ImmunityBio, Inc.'s warrants and rights outstanding?
- ImmunityBio, Inc. (IBRX) reported warrants and rights outstanding of 47.9M in Q1 2026.
- How has ImmunityBio, Inc.'s warrants and rights outstanding changed year-over-year?
- ImmunityBio, Inc.'s warrants and rights outstanding increased by 647.9% year-over-year, from 6.4M to 47.9M.
- What is the long-term trend for ImmunityBio, Inc.'s warrants and rights outstanding?
- Over 2 years (2023 to 2025), ImmunityBio, Inc.'s warrants and rights outstanding has grown at a 31.3% compound annual growth rate (CAGR), from 37.7M to 65.1M.